Current and historical daily PE Ratio for KARBF (
Karo Pharma AB
) from 1990 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Karo Pharma AB stock (KARBF) PE ratio as of Jun 06 2024 is 0.
More Details
Karo Pharma AB (KARBF) PE Ratio (TTM) Chart
Karo Pharma AB (KARBF) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1169
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Karo Pharma AB PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | At Loss | 2023-12-15 | At Loss |
| 2024-02-21 | At Loss | 2023-12-14 | At Loss |
| 2024-02-20 | At Loss | 2023-12-13 | At Loss |
| 2024-02-16 | At Loss | 2023-12-12 | At Loss |
| 2024-02-15 | At Loss | 2023-12-11 | At Loss |
| 2024-02-14 | At Loss | 2023-12-08 | At Loss |
| 2024-02-13 | At Loss | 2023-12-07 | At Loss |
| 2024-02-12 | At Loss | 2023-12-06 | At Loss |
| 2024-02-09 | At Loss | 2023-12-05 | At Loss |
| 2024-02-08 | At Loss | 2023-12-04 | At Loss |
| 2024-02-07 | At Loss | 2023-12-01 | At Loss |
| 2024-02-06 | At Loss | 2023-11-30 | At Loss |
| 2024-02-05 | At Loss | 2023-11-29 | At Loss |
| 2024-02-02 | At Loss | 2023-11-28 | At Loss |
| 2024-02-01 | At Loss | 2023-11-27 | At Loss |
| 2024-01-31 | At Loss | 2023-11-22 | At Loss |
| 2024-01-30 | At Loss | 2023-11-21 | At Loss |
| 2024-01-29 | At Loss | 2023-11-20 | At Loss |
| 2024-01-26 | At Loss | 2023-11-17 | At Loss |
| 2024-01-25 | At Loss | 2023-11-16 | At Loss |
| 2024-01-24 | At Loss | 2023-11-15 | At Loss |
| 2024-01-23 | At Loss | 2023-11-14 | At Loss |
| 2024-01-22 | At Loss | 2023-11-13 | At Loss |
| 2024-01-19 | At Loss | 2023-11-10 | At Loss |
| 2024-01-18 | At Loss | 2023-11-09 | At Loss |
| 2024-01-17 | At Loss | 2023-11-08 | At Loss |
| 2024-01-16 | At Loss | 2023-11-07 | At Loss |
| 2024-01-12 | At Loss | 2023-11-06 | At Loss |
| 2024-01-11 | At Loss | 2023-11-03 | At Loss |
| 2024-01-10 | At Loss | 2023-11-02 | At Loss |
| 2024-01-09 | At Loss | 2023-11-01 | At Loss |
| 2024-01-08 | At Loss | 2023-10-31 | At Loss |
| 2024-01-05 | At Loss | 2023-10-30 | At Loss |
| 2024-01-04 | At Loss | 2023-10-27 | At Loss |
| 2024-01-03 | At Loss | 2023-10-26 | At Loss |
| 2024-01-02 | At Loss | 2023-10-25 | At Loss |
| 2023-12-29 | At Loss | 2023-10-24 | At Loss |
| 2023-12-28 | At Loss | 2023-10-23 | At Loss |
| 2023-12-27 | At Loss | 2023-10-20 | At Loss |
| 2023-12-26 | At Loss | 2023-10-19 | At Loss |
| 2023-12-22 | At Loss | 2023-10-18 | At Loss |
| 2023-12-21 | At Loss | 2023-10-17 | At Loss |
| 2023-12-20 | At Loss | 2023-10-16 | At Loss |
| 2023-12-19 | At Loss | 2023-10-13 | At Loss |
| 2023-12-18 | At Loss | 2023-10-12 | At Loss |
Karo Pharma AB (KARBF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Karo Pharma AB
NAICS : 325412
ISIN : SE0007464888
Description
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers